One-Year Experience with NORPLANT Implants in Indonesia

Lubis, Firman; Prihartono, Joedo; Agoestina, T; Affandi, Biran; Sutedi, Hermini

doi:10.2307/1965498

Cited by 39 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In clinical studies 40-60% of users discontinued the use of Norplant implants in the first year of use 37,38 . Our previous studies 17,18 , had reported irregular reduced bleeding pattern amongst the acceptors over 36months of use.…”

Section: Discussionmentioning

confidence: 99%

Contraception with Levonorgestrel Subdermal Implants ($Norplant^R$) in Benin-City, Nigeria: A 12-year Review

Aisien¹

2007

African Journal of Reproductive Health

View full text Add to dashboard Cite

The case notes of 377 clients who accepted Norplant out of 11961 acceptors of family planning methods in the Department of Obstetrics and Gynaecology University of Benin Teaching Hospital, between January 1985 and December 1996 were retrieved and analysed at the end of 2004, for socio-demographic characteristics of the clients, side effects and complications reported and reasons for discontinuation in relation to duration of use. The daily register of the acceptors were analysed for new acceptors of other methods during the same period and confirmed with their case notes. The acceptance incidence of Norplant was 3.2%. The mean age and parity of the acceptors were 32.2 ± 4.5years and 3.9 ± 1.8 respectively. The duration of use ranged between 6 months and 13 years. 65% of the acceptors reported menstrual abnormalities. 48% of them reported reduced bleeding pattern, while 7.5% (25) discontinued method under 4years of use because of increased bleeding episodes. Other side effects reported were headache 6%, weight gain 3%, mastalgia 1.8%, decreased libido 1.8%, abdominal pain 1.5% and hypertension 1.2%. 20.4% (68) discontinued the use under 4years because of desire to have another baby. 38.6% (129) had implants removed at 5years, while 20.1% (67) continued the use for 6-13years before removal and replacement with another set. Husband's request for removal constituted 7.2% (24). The effectiveness was 100% as no pregnancy was reported during the study period. The continuation rate at 5years was 58.7%. 43 clients were however lost to follow up. Norplant was found to be an effective and acceptable method of long-term reversible contraception with minimal side effects. The low incidence was attributed to the fact that the implants were donor driven and not included in the country contraceptive logistic system. Norplant acceptors who continued the use after 5years did so, because they enjoyed it and did not want to part with them without replacement of new sets. Les dossiers ont été analysés pour identifier les caractéristiques socio-démographiques des clientes, les effets secondaires et les complications signalées et les raisons pour l'arrêt par rapport à la durée de l'emploi. Le registre quotidien d'accepteurs a été analysé pour identifier les nouveaux accepteurs d'autres méthodes pendant la même période avant de les confirmer avec leurs dossiers. L'incidence de l'acceptation de Norplant était de 3,2%. L'âge moyen et la parité des accepteurs étaient de 32,2 ± 4, 5 ans et 3, 9 ± 1, 8 respectivement. La durée de l'emploi variait entre six mois et 13 ans. 65% des accepteurs ont signalé les anomalies menstruelles. 48% parmi elles ont signalé une habitude d'une hémorragie réduite, alors que 7,5%(25) ont arrêté l'emploi de la méthode en moins de quatre ans à cause des crises d'hémorragie. Autres effets secondaires signalés étaient maux de tête 6%, prise de poids 3%, mastalgie 1,8%, baisse de la libido 1,8%, douleur abdominale 1,5%, hypertension 1,2%. 20,4% (68) ont arrête l'emploi en moins de 4 ans parce qu'elles voula...

show abstract

Section: Discussionmentioning

confidence: 99%

Contraception with Levonorgestrel Subdermal Implants ($Norplant^R$) in Benin-City, Nigeria: A 12-year Review

Aisien¹

2007

African Journal of Reproductive Health

View full text Add to dashboard Cite

show abstract

“…Vaginal bleeding is a leading reason for Norplant removal [12,15,16]. Noerpramana reported that 2 acceptors out of 714 asked for removal because of prolonged vaginal bleeding, 2 acceptors because of pain, and 1 because of irritation at the site of implantation [17].…”

Section: Introductionmentioning

confidence: 99%

Factors influencing attitudes about Norplant contraceptive subdermal implant

Rusbandi

1993

Adv Contracept

View full text Add to dashboard Cite

show abstract

“…Second, in what respects do the women who want to use Norplant for limiting childbearing differ from those who want to use Norplant for pregnancy spacing? [3] 40.4 324 Colombia [4] 51.0 389 Egypt [5] 6.0 250 Haiti [6] 52.8 250 Indonesia [7] 45.0 813 Nepal [8] 80.1 307 Nigeria [9] 54.4 250 Philippines [10] 69.0 100 Santo Domingo, ~ 56.0 200 Dominican Republic [11] ~ 39.2 212 Singapore [12] 69.0 100 Sri Lanka [13] 48.0 400 * Norplant is the registered trademark of the Population Council for subdermal contraceptive implants.…”

Section: Introductionmentioning

confidence: 99%

Potential acceptors of Norplant implants in comparison with recently sterilized women in Sri Lanka

Thapa

Silva²,

Farr

1989

Adv Contracept

View full text Add to dashboard Cite

This paper analyzes data from a population-based survey fielded in Sri Lanka, which showed that almost half of the women interested in using Norplant contraceptive subdermal implants were actually those who wanted to limit childbearing, a pattern also found in international Norplant clinical studies. A comparison between recently sterilized women and professed limiters of potential Norplant users showed the limiters to be socio-economically and demographically a significantly different group of women from those sterilized. Among several variables analyzed, the most important factor distinguishing the two groups was their relative economic status. Further comparison of the limiters with professed spacers interested in using Norplant showed that the spacers were yet another distinct category of women, the most important characteristic distinguishing between the two groups being the total number of living children. The preliminary results suggest that the Norplant implants system is not necessarily a substitute for sterilization; it appears potentially a popular method among those who want no more children but are not ready to accept sterilization. These findings that the potential Norplant implant users represent different gradients of women in the population have implications for provider counseling and user satisfaction as well as continuation.

show abstract

One-Year Experience with NORPLANT Implants in Indonesia

Cited by 39 publications

References 0 publications

Contraception with Levonorgestrel Subdermal Implants ($Norplant^R$) in Benin-City, Nigeria: A 12-year Review

Contraception with Levonorgestrel Subdermal Implants ($Norplant^R$) in Benin-City, Nigeria: A 12-year Review

Factors influencing attitudes about Norplant contraceptive subdermal implant

Potential acceptors of Norplant implants in comparison with recently sterilized women in Sri Lanka

Contact Info

Product

Resources

About